Clinical trial
Melphalan Intra-arterial Chemotherapy for Choroidal Melanoma Chemoreduction - a Phase I Clinical Trial
NCT05893654 is registered in ClinicalTrials.gov with Hospital das Clínicas de Ribeirão Preto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Melphalan Intra-arterial Chemotherapy for Choroidal Melanoma Chemoreduction - a Phase I Clinical Trial
- Lead sponsor
- Hospital das Clínicas de Ribeirão Preto
- Phase
- Phase 1/2
- Overall status
- Enrolling by invitation
- Start date
- May 1, 2021
- Completion date
- December 31, 2025
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.